Human NK Cells in Health and Disease: Clinical, Functional, Phenotypic and DNA Genotypic Characteristics
- 1 January 1992
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 7 (5) , 377-399
- https://doi.org/10.3109/10428199209049794
Abstract
Natural killer (NK) cells are the subject of great current interest because of their possible (in vivo) role in tumour cell surveillance and killing, and because of the potential application of cytokine-modulated NK cells in cancer immunotherapy. In addition, clonal proliferations of NK-associated (NKa) cell populations represent a high proportion of chronic (non-B) lymphoid malignancies and abnormal (both clonal and non-clonal) NKa components are being increasingly reported in association with diverse clinical pictures such as autoimmune disease. This communication extensively reviews what is presently known regarding normal and leukaemic NKa phenotypic diversity, the mechanisms of NK-mediated cytolysis, the role of NK cells in malignancy, and the diagnostic and cellular aspects of malignant NKa proliferations.Keywords
This publication has 187 references indexed in Scilit:
- Perforin-induced pore formationImmunology Today, 1991
- Lymphocyte-triggered internal target disintegrationImmunology Today, 1991
- The Role of Natural Killer Cells in Immune SurveillanceNew England Journal of Medicine, 1989
- Severe Herpesvirus Infections in an Adolescent without Natural Killer CellsNew England Journal of Medicine, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Evidence for three types of human cytotoxic lymphocyteImmunology Today, 1986
- Rearrangements of Genes for the Antigen Receptor on T Cells as Markers of Lineage and Clonality in Human Lymphoid NeoplasmsNew England Journal of Medicine, 1985
- T-Cell Receptor Gene Rearrangements as Clinical Markers of Human T-Cell LymphomasNew England Journal of Medicine, 1985
- Rearrangement of the Gene for the Beta Chain of the T-Cell Receptor in T-Cell Chronic Lymphocytic Leukemia and Related DisordersNew England Journal of Medicine, 1985